NovaBay Pharmaceuticals, Inc. Common Equity (Total)

Common Equity (Total) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Common Equity (Total) growth rates and interactive chart.


Highlights and Quick Summary

  • Common Equity (Total) for the quarter ending June 30, 2022 was $15.2 Million (a -11.45% decrease compared to previous quarter)
  • Year-over-year quarterly Common Equity (Total) increased by 62.06%
  • Annual Common Equity (Total) for 2021 was $9.49 Million (a -22.95% decrease from previous year)
  • Annual Common Equity (Total) for 2020 was $12.3 Million (a 1165.98% increase from previous year)
  • Annual Common Equity (Total) for 2019 was $973 Thousand (a -80.36% decrease from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Common Equity (Total) of NovaBay Pharmaceuticals, Inc.

Most recent Common Equity (Total)of NBY including historical data for past 10 years.

Interactive Chart of Common Equity (Total) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Common Equity (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $15.18 $17.14
2021 $9.49 $9.36 $11.21 $10.98 $9.49
2020 $12.32 $13.88 $0.98 $-0.35 $12.32
2019 $0.97 $2.92 $1.67 $1.13 $0.97
2018 $4.95 $6.06 $7.43 $8.87 $4.95
2017 $2.59 $1.83 $3.21 $4.36 $2.59
2016 $7.1 $6.72 $-2.47 $-7.3 $7.1
2015 $-5.1 $0.23 $4.9 $2.15 $-5.1
2014 $1.85 $5.69 $9.22 $11.84 $1.85
2013 $8.52 $5.42 $7.21 $10.34 $8.52
2012 $14.05 $7.44 $5.61 $7.37 $14.05
2011 $9.34 $9.34

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology